Skip to Main Content

Paper Details

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
BMC Cancer
12
2020
Author NameAffiliation
Martina KluthInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Claudia Hube-MaggInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Hartwig HulandMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Thorsten SchlommCharite - Universitatsmedizin Berlin
  • 1 - 7

Datasets

Release 1.2